Department of Medicine, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA 19104.
Department of Systems Pharmacology and Translational Therapeutics, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA 19104.
Proc Natl Acad Sci U S A. 2020 Sep 29;117(39):24316-24325. doi: 10.1073/pnas.2007642117. Epub 2020 Sep 14.
Platelets are best known for their vasoprotective responses to injury and inflammation. Here, we have asked whether they also support vascular integrity when neither injury nor inflammation is present. Changes in vascular barrier function in dermal and meningeal vessels were measured in real time in mouse models using the differential extravasation of fluorescent tracers as a biomarker. Severe thrombocytopenia produced by two distinct methods caused increased extravasation of 40-kDa dextran from capillaries and postcapillary venules but had no effect on extravasation of 70-kDa dextran or albumin. This reduction in barrier function required more than 4 h to emerge after thrombocytopenia was established, reverting to normal as the platelet count recovered. Barrier dysfunction was also observed in mice that lacked platelet-dense granules, dense granule secretion machinery, glycoprotein (GP) VI, or the GPVI signaling effector phospholipase C (PLC) γ2. It did not occur in mice lacking α-granules, C type lectin receptor-2 (CLEC-2), or protease activated receptor 4 (PAR4). Notably, although both meningeal and dermal vessels were affected, intracerebral vessels, which are known for their tighter junctions between endothelial cells, were not. Collectively, these observations 1) highlight a role for platelets in maintaining vascular homeostasis in the absence of injury or inflammation, 2) provide a sensitive biomarker for detecting changes in platelet-dependent barrier function, 3) identify which platelet processes are required, and 4) suggest that the absence of competent platelets causes changes in the vessel wall itself, accounting for the time required for dysfunction to emerge.
血小板以其对损伤和炎症的血管保护反应而闻名。在这里,我们想知道,在既没有损伤也没有炎症的情况下,它们是否也能支持血管完整性。我们使用荧光示踪剂的差异渗出作为生物标志物,实时测量了皮肤和脑膜血管中血管屏障功能的变化。两种不同方法引起的严重血小板减少导致 40kDa 葡聚糖从毛细血管和小静脉后毛细血管渗出增加,但对 70kDa 葡聚糖或白蛋白的渗出没有影响。这种屏障功能的降低在血小板减少症确立后需要 4 个多小时才会出现,并随着血小板计数的恢复而恢复正常。缺乏血小板致密颗粒、致密颗粒分泌机制、糖蛋白 (GP) VI 或 GPVI 信号效应磷脂酶 C (PLC) γ2 的小鼠也观察到了屏障功能障碍。缺乏 α-颗粒、C 型凝集素受体 2 (CLEC-2) 或蛋白酶激活受体 4 (PAR4) 的小鼠则没有发生这种情况。值得注意的是,尽管脑膜和皮肤血管都受到影响,但已知内皮细胞之间紧密连接的脑内血管则没有受到影响。总的来说,这些观察结果 1) 强调了血小板在没有损伤或炎症的情况下维持血管内稳态的作用,2) 提供了一种检测血小板依赖性屏障功能变化的敏感生物标志物,3) 确定了哪些血小板过程是必需的,4) 表明功能失调的出现需要有功能的血小板,这可能导致血管壁本身发生变化。